Life Sciences Portfolio

The following is the list of companies currently in the Life Sciences portfolio. Click on the company name to follow a link to their web site (where applicable).


4-Antibody	Novel technology for developing new antibodies Advent Contact: Raj Parekh
Algeta	Novel anticancer agents based on alpha emitters Oslo Bors IPO March 2007 (ALGETA) Advent Contact: Shahzad Malik
AMT	Gene therapy for orphan indications Euronext IPO June 2007 (AMT) Advent Contact: Raj Parekh
Avila	Development of novel small molecule drugs focused on cancer, autoimmune diseases and viral infection Advent Contact: Raj Parekh
Biocartis	Development of a novel molecular diagnostics platform Advent Contact: Raj Parekh
CardiacAssist	Extracorporeal ventricular assist device Advent Contact: Shahzad Malik
CardioKine	Cardio-renal drug development Advent Contact: Shahzad Malik
Cellnovo	Development of next-generation small disposable insulin pumps Advent Contact: Raj Parekh
Conatus Pharmaceuticals	New therapeutic agents for treatment of liver disease Advent Contact: Shahzad Malik
EUSA Pharma	Trans-Atlantic speciality pharmaceutical company Advent Contact: Raj Parekh
Infinity Pharmaceuticals	Chemical genomic based drug discovery NASDAQ: INFI Advent Contact: Shahzad Malik
MediGene	Development of anti-cancer drugs Frankfurt, Prime Standard: MDG Advent Contact: Raj Parekh
Micromet	Develops novel antibody-based drugs for treatment of cancer, inflammation and autoimmune diseases NASDAQ: MITI Advent Contact: Don Drakeman
Oxagen	Development of small molecule treatment for asthma Advent Contact: Kaasim Mahmood
Pathwork Diagnostics	Molecular diagnostic tests for cancer Advent Contact: Shahzad Malik
RespiVert	Discovery company focused on respiratory diseases and severe asthma Advent Contact: Shahzad Malik
Santarus	Drug development with gastrointestinal disease focus NASDAQ:SNTS Advent Contact: Kaasim Mahmood
Speciality European Pharma	Speciality therapeutic products for the European market Advent Contact: Shahzad Malik